Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Structure Therapeutics

Explore full profile

Specializes in the discovery and development of drugs against a type of targets called GPCR

South San Francisco, United StatesFounded 2016Biotech & Life Sciences
Valuation $1.96B Market cap · 2026
Revenue $38M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Structure Therapeutics

Structure Therapeutics is a clinical-stage biopharmaceutical company that specializes in the discovery and development of oral small molecule therapeutics for the treatment of chronic metabolic diseases. The company leverages its expertise in structure-based drug design to create more accessible and effective treatments.

Read full description

Operating in the biopharmaceutical market, Structure Therapeutics focuses on developing innovative drugs for a range of metabolic disorders. Its business model is centered on a science-driven approach to drug discovery, advancing promising candidates through clinical trials. The company generates revenue through the development and commercialization of its proprietary drug candidates.

Source: Dealroom company data

At a glance

Founded
2016
Headquarters
South San Francisco, United States
Listing
IPO 2023
Sector
Biotech & Life Sciences
Power Law
Unicorn$1–10B valuation tierColt$25–100M revenue

Research & analysis

From the Dealroom knowledge graph
Market map Peptides: The Next Drug Modality Stack Apr 10, 2026

Latest news

Press, funding announcements and product moves mentioning Structure Therapeutics.

See all news

Investors

22 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A12 investors entered at this stage

Series B and later10 investors entered at this stage

  • Monashee Capital Corp.
  • Terra Magnum Capital Partners
  • Piper Heartland Healthcare Capital
  • Sage Partners
  • Citadel
  • Janus Henderson Investors
  • Sequoia
  • Deep Track Capital
  • Woodline Partners
  • Stork Capital

Talent

Book a demo to see the people
Employees mapped 239 incl. 2 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
7 countries with
team presence
🇺🇸 United States75.3%
🇨🇳 China20%
🇬🇧 United Kingdom1.3%
🇨🇭 Switzerland0.7%
🇳🇱 Netherlands0.7%
Top 5 of 7 shown
Web traffic by country
13K monthly visits
across markets
🇺🇸 United States54.6%
🏳️ Korea14.6%
🏳️ Republic of13.1%
🇦🇺 Australia9.2%
🇮🇳 India6.2%
Top 5 markets shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Structure Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Structure Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles